References [1]  Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 2021; 9: 373–92. [2]  Institute ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

This story contains details from testimony referencing suicide and suicidal ideations that are graphic, and some readers may ...

Innovent announces phase 3 study of mazdutide in Chinese adults with overweight or obesity (GLORY-1) published in the NEJM: San Francisco, US Tuesday, May 27, 2025, 11:00 Hrs [IST ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

Mazdutide is expected to launch in China this year, with anticipated approvals for weight management and glycemic control.

A pilot study from Michigan Medicine researchers found that the Mediterranean diet may provide symptom relief for people with ...

Rocket Pharmaceuticals shares plummeted 60% Tuesday after the firm said it halted a study of a gene-therapy drug for Danon ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Nearly thirty years ago an academic paper wrongly linked autism to a measles vaccine. The impacts are still being felt today.

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

An updated framework for addressing traumatic brain injury places the focus on the acute phase, while considering internal, external and modifying factors that influence outcomes from these events, ...